# A Study of BYN-001 in Healthy Adults and in Adults With Moderate to Severe Atopic Dermatitis

> **NCT07746817** · PHASE1 · RECRUITING · sponsor: **Bionyra Pharma** · enrollment: 56 (estimated)

## Conditions studied

- Atopic Dermatitis
- Healthy Participants

## Interventions

- **BIOLOGICAL:** BYN-001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07746817
- **Lead sponsor:** Bionyra Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-17
- **Primary completion:** 2028-06-01
- **Final completion:** 2028-12-31
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2026-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07746817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07746817, "A Study of BYN-001 in Healthy Adults and in Adults With Moderate to Severe Atopic Dermatitis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07746817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*